EU awards HIL Applied Medical with €2.5M in Grant Funding
The European Commission managing Horizon 2020 – the EU Framework Programme for Research and Innovation – approved HIL’s Phase-II proposal, at a total budget of
Atox Bio gets BARDA Support for Continued Development of Reltecimod for Necrotizing Soft Tissue Infections
Atox Bio, a late-stage clinical company developing immunotherapies for critically ill patients, announced that the Biomedical Advanced Research and Development Authority (BARDA) has exercised the
KAHR Medical Announces Clinical Trial Collaboration with ROCHE in Advanced Lung Cancer Patients
KAHR Medical Ltd , a biopharmaceutical company developing a novel drug platform based on bi-functional, immunotherapeutic fusion proteins known as DSP (Dual Signaling Proteins), announced
Betalin Therapeutics’s Micro Pancreas Ready for Human Trials
Betalin Therapeutics‘ Micro Pancreas will be tested on humans within 12 months. The biological pancreas contains living islet cells that are able to produce insulin but need
Future Meat Technologies raises $14m in Seed Funding
Israeli start-up Future Meat Technologies has secured $14 million in a seed funding round as it intends to build the world’s first cultured meat pilot

Carolina Partners Expands Treatment Offerings to Include Revolutionary Brainsway Therapy for OCD
Carolina Partners, one of the most prominent mental and behavioral practices in the country, announced plans to offer patients access to BrainsWay‘s Deep Transcranial Magnetic

European Investment Bank VP Attends Signature Event at BiondVax Extending Financing to €24million
The Board of Directors and Management of BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), was honored to host Mr. Ambroise Fayolle, Vice-President of the European Investment Bank

Oramed Provides Clinical Update with Meaningful Data Expected by Year-End
Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) , a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today provided a clinical update regarding four ongoing
New York Arcview Investor Forum Honors “Father of Cannabis Research” Raphael Mechoulam with $10K Award
The Arcview Group will honor “The Father of Cannabis Research” with a Lifetime Achievement Award and a $10,000 research grant in their first annual cannabis